RE:RE:Asco Gu abstract releasedIt's good to remember that 8 of the 24 evaluable patients were undertreated and did not receive an optimized treatment. So 33% of the sample of 24 patients had no chance of a CR.
21% CR at 450 days in no way reflects the actual efficacy of the treatment.
As mentioned by DJDawg, in the more recent data release from Nov. 29 the CR rate at 450 days was 28%. If just 2 of the 8 completely underdosed patients (25%) had attained a durable CR we would now be able to brag about a 450 day durable CR of 35%
As more patients are treated the durable CR rate will continue to improve.